<DOC>
	<DOCNO>NCT01626521</DOCNO>
	<brief_summary>To access clinical usefulness F1+2 diagnosis PE patient AECOPD require hospitalization . Specifically , determine whether F1+2 may additional value subgroup patient abnormal D-dimer , determine whether may increase proportion patient PE safely rule determine sensitivity , specificity NPV F1+2 various cut-off value .</brief_summary>
	<brief_title>Value Prothrombin Fragment F1+2 Diagnosis Pulmonary Embolism Patients With Chronic Obstructive Pulmonary Disease ( COPD ) Exacerbation</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<criteria>COPD exacerbation Able give inform consent Able perform spirometry Known malignancy Known hypercoagulable state Receiving anticoagulant treatment Pregnancy Renal failure Allergy iodine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>